Intraoperative Pain during Restorative Treatment of Maxillary First Permanent Molars Using Artpharma versus Artinibsa in Children after Infiltration Technique: A Randomized Controlled Clinical Trial

Alaidaros, Amani Hamed; Elmotayam, Kamal Eldin; Abdelgawad, Fatma

doi:10.21608/adjc.2023.215736.1335

Intraoperative Pain during Restorative Treatment of Maxillary First Permanent Molars Using Artpharma versus Artinibsa in Children after Infiltration Technique: A Randomized Controlled Clinical Trial

Document Type : Original Article

Authors

¹ Pediatric Dentistry, Faculty of Dentistry, Cairo University.

² Pediatric Dentistry and Dental Public Health Department, Faculty of Dentistry, Cairo University, Cairo, Egypt.

³ Faculty of Dentistry- Cairo University

10.21608/adjc.2023.215736.1335

Abstract

Aim: The aim of this study is to assess intraoperative pain during restorative treatment of maxillary first permanent molars using Artpharma versus Artinibsa in children after infiltration technique.
Materials and methods: This study is a randomized controlled clinical trial in which 46 children aged from 8-10 years old with maxillary permanent molars indicated for Class I restorative treatment were recruited from the outpatient diagnostic clinic in Pediatric Dentistry and Dental Public Health Department, Faculty of Dentistry, Cairo University, and randomly assigned to intervention and control groups. Each child received a maxillary infiltration anesthesia using a 4% Articaine (Artpharma) 1:100000 anesthetic solution, while in the control group, they received a 4% Articaine (Artinibsa) 1:100000 solution. The pain scale was used to record intra-operative pain during the procedure.
Results: Regarding frequency and percentage values for Wong-Baker Faces Pain Rating Scales there was no statistically significant difference between both groups (p=0.135). Success rate results showed single case failed in control group, while in the intervention group all cases were successful and the difference between both groups was not statistically significant difference (p=1).
Conclusions: Both Artpharma and Artinibsa are successful in controlling intraoperative pain during restorative treatment of maxillary first permanent molars.

Keywords